Stephen H. LaFranchi, M.D.

  • Adjunct Professor of Pediatrics, Division of Endocrinology, School of Medicine
  • Endocrine Consultant to the Newborn Screening Program
  • Principal investigator on TRIAC II Trial in patients with Allan-Herndon-Dudley Syndrome


Dr. LaFranchi specializes in caring for children with gland or hormone problems. He cares for children referred to the Doernbecher Children’s Hospital Pediatric Endocrinology Specialty Clinic for evaluation of concerns about growth, early or delayed puberty, and disorders of the thyroid, adrenal or pituitary gland. Children are seen together with the Fellow in Pediatric Endocrinology.

Dr. LaFranchi is the medical consultant for the Oregon Newborn Screening Program and so has a special interest in the two endocrine disorders, congenital hypothyroidism and congenital adrenal hyperplasia.

Education and training

    • M.D., 1969, University of California at Los Angeles (UCLA)
  • Residency

    • University of California at Los Angeles (UCLA) 1969-1972
  • Fellowship

    • University of California at Los Angeles (UCLA) 1972-1975
  • Certifications

    • American Board of Pediatrics 1974 (lifetime certification)
    • American Board of Pediatrics, sub-specialty certification in Pediatric Endocrinology 1978 (lifetime certification)
    • American Board of Pediatrics, voluntarily re-certified in 1993

Memberships and associations:

  • The Pediatric Endocrine Society
  • The Endocrine Society
  • American Thyroid Association
  • American Pediatric Society
  • Society for Pediatric Research
  • Western Society for Pediatric Research
  • American Academy of Pediatrics
  • The Oregon Pediatric Society

Areas of interest

  • Thyroid hormone physiology
  • Pediatric thyroid disease
  • Clinical Care
  • Clinical Research
  • Education


Selected publications

  • Eshragh N, Doan L, Connelly K. Ouctome of newborn screening for congenital adrenal hyperplasia at two time points. Horm Res Paediatr 2020.


  • {{[0].value }}